Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines

Ann Oncol. 2010 May:21 Suppl 5:v277-82. doi: 10.1093/annonc/mdq200.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / radiotherapy
  • Europe / epidemiology
  • Female
  • Heart Diseases / drug therapy*
  • Heart Diseases / etiology
  • Hodgkin Disease / radiotherapy
  • Humans
  • Incidence
  • Meta-Analysis as Topic
  • Radiotherapy / adverse effects*
  • Risk Factors

Substances

  • Antineoplastic Agents